Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes

Journal of Neural Transmission

Volumn 123, Issue 5, 2016, Pages 541-548

  Kovacs, David ^a,b   Eszlari, Nora ^a,b   Petschner, Peter ^a,b   Pap, Dorottya ^a   Vas, Szilvia ^a,b   Kovacs, Peter ^a,c   Gonda, Xenia ^a,b   Bagdy, Gyorgy ^a,b   Juhasz, Gabriella ^a,b,d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Depression; Interleukin 6; Pain; Polymorphism; Stress; Zung Self rating Scale

Indexed keywords

INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BRIEF SYMPTOM INVENTORY; DEPRESSION; FEMALE; GENOTYPE; HERITABILITY; HUMAN; HUNGARIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; PAIN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; PROTEIN POLYMORPHISM; STRESS; ZUNG SELF RATING DEPRESSION SCALE; ADOLESCENT; COMPLICATION; GENETICS; MENTAL STRESS; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; DEPRESSIVE DISORDER; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; PAIN; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PSYCHIATRIC STATUS RATING SCALES; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84955604619     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-016-1506-9     Document Type: Article

References (44)

1. Arruda JL, Colburn RW, Rickman AJ, Rutkowski MD, DeLeo JA (1998) Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: potential role of IL-6 in neuropathic pain. Brain Res Mol Brain Res 62:228–235
2. Baune BT et al (2012) Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain. J Neuroinflammation 9:125. doi:10.1186/1742-2094-9-125
3. Bob P et al (2010) Depression, traumatic stress and interleukin-6. J Affect Disord 120:231–234. doi:10.1016/j.jad.2009.03.017
4. Brenn D, Richter F, Schaible HG (2007) Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis Rheum 56:351–359. doi:10.1002/art.22282
5. Brugha T, Bebbington P, Tennant C, Hurry J (1985) The list of threatening experiences: a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med 15:189–194
6. Bull SJ et al (2009) Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry 14:1095–1104. doi:10.1038/mp.2008.48
7. Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R (2002) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7:468–473. doi:10.1038/sj.mp.4000995
8. De Jongh RF, Vissers KC, Meert TF, Booij LH, De Deyne CS, Heylen RJ (2003) The role of interleukin-6 in nociception and pain. Anesth Analg 96:1096–1103 (table of contents)
9. Derogatis LR, Melisaratos N (1983) The Brief Symptom Inventory: an introductory report. Psychol Med 13:595–605
10. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446–457. doi:10.1016/j.biopsych.2009.09.033
11. Dunn AJ, Swiergiel AH, de Beaurepaire R (2005) Cytokines as mediators of depression: What can we learn from animal studies? Neurosci Biobehav Rev 29:891–909. doi:10.1016/j.neubiorev.2005.03.023
12. Faltraco F et al (2003) Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer’s disease risk. J Am Geriatr Soc 51:578–579
13. Fife MS, Ogilvie EM, Kelberman D, Samuel J, Gutierrez A, Humphries SE, Woo P (2005) Novel IL-6 haplotypes and disease association. Genes Immun 6:367–370. doi:10.1038/sj.gene.6364186
14. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376. doi:10.1172/JCI2629
15. Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW (2003) DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet 33:67–72
16. Gonda X, Juhasz G, Laszik A, Rihmer Z, Bagdy G (2005) Subthreshold depression is linked to the functional polymorphism of the 5HT transporter gene. J Affect Disord 87:291–297. doi:10.1016/j.jad.2005.05.007
17. Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71:171–186. doi:10.1097/PSY.0b013e3181907c1b
18. Illman J, Corringham R, Robinson D Jr, Davis HM, Rossi JF, Cella D, Trikha M (2005) Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol 3:37–50
19. Kelberman D, Fife M, Rockman MV, Brull DJ, Woo P, Humphries SE (2004) Analysis of common IL-6 promoter SNP variants and the AnTn tract in humans and primates and effects on plasma IL-6 levels following coronary artery bypass graft surgery. Biochim Biophys Acta 1688:160–167. doi:10.1016/j.bbadis.2003.11.010
20. Kitamura T, Hirano H, Chen Z, Hirata M (2004) Factor structure of the Zung Self-rating Depression Scale in first-year university students in Japan. Psychiatry Res 128:281–287. doi:10.1016/j.psychres.2004.06.003
21. Kovacs P, Panczel G, Balatoni T, Liszkay G, Gonda X, Bagdy G, Juhasz G (2015) Social support decreases depressogenic effect of low-dose interferon alpha treatment in melanoma patients. J Psychosom Res 78:579–584. doi:10.1016/j.jpsychores.2015.03.005
22. Lazary J, Lazary A, Gonda X, Benko A, Molnar E, Juhasz G, Bagdy G (2008) New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype. Biol Psychiatry 64:498–504. doi:10.1016/j.biopsych.2008.03.030
23. Loftis JM et al (2013) Vulnerability to somatic symptoms of depression during interferon-alpha therapy for hepatitis C: a 16-week prospective study. J Psychosom Res 74:57–63. doi:10.1016/j.jpsychores.2012.10.012
24. Lu S et al (2013) Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis. Compr Psychiatry 54:953–961. doi:10.1016/j.comppsych.2013.03.026
25. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR (2008) Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry 64:484–490. doi:10.1016/j.biopsych.2008.04.016
26. McAfoose J, Baune BT (2009) Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev 33:355–366. doi:10.1016/j.neubiorev.2008.10.005
27. McEwen BS (2000) The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886:172–189
28. Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T (2008) A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11:198–209. doi:10.1080/10253890701754068
29. Mokrani MC, Duval F, Crocq MA, Bailey P, Macher JP (1997) HPA axis dysfunction in depression: correlation with monoamine system abnormalities. Psychoneuroendocrinology 22(Suppl 1):S63–S68
30. Molina-Holgado E, Molina-Holgado F (2010) Mending the broken brain: neuroimmune interactions in neurogenesis. J Neurochem 114:1277–1290. doi:10.1111/j.1471-4159.2010.06849.x
31. Slavich GM, Irwin MR (2014) From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 140:774–815. doi:10.1037/a0035302
32. Smolen JS et al (2008) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 371:987–997. doi:10.1016/S0140-6736(08)60453-5
33. Tate DG, Forscheimer M, Maynard F, Davidoff G, Dijkens M (1993) Comparing two measures of depression in spinal cord injury Rehabilitational. Psychology 38:53–61
34. Terry CF, Loukaci V, Green FR (2000) Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275:18138–18144. doi:10.1074/jbc.M000379200
35. Tilg H, Dinarello CA, Mier JW (1997) IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 18:428–432
36. Udina M et al (2013) Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms. Psychoneuroendocrinology 38:1803–1813. doi:10.1016/j.psyneuen.2013.03.007
37. Vallieres L, Campbell IL, Gage FH, Sawchenko PE (2002) Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci 22:486–492
38. Wagner JA (1996) Is IL-6 both a cytokine and a neurotrophic factor? J Exp Med 183:2417–2419
39. Walker AK, Kavelaars A, Heijnen CJ, Dantzer R (2014) Neuroinflammation and comorbidity of pain and depression. Pharmacol Rev 66:80–101. doi:10.1124/pr.113.008144
40. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH (2001) Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford) 40:743–749
41. Wu D et al (2011) The association of genetic polymorphisms with cerebral palsy: a meta-analysis. Dev Med Child Neurol 53:217–225. doi:10.1111/j.1469-8749.2010.03884.x
42. Yan J, Melemedjian OK, Price TJ, Dussor G (2012) Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). Mol Pain 8:6. doi:10.1186/1744-8069-8-6
43. Zakharyan R, Petrek M, Arakelyan A, Mrazek F, Atshemyan S, Boyajyan A (2012) Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia. Tissue Antigens 80:136–142. doi:10.1111/j.1399-0039.2012.01886.x
44. Zung WW, Richards CB, Short MJ (1965) Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 13:508–515